Cargando…

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer

Intratumoral androgen biosynthesis has been recognized as an essential factor of castration‐resistant prostate cancer. The present study investigated the effects of curcumin on the inhibition of intracrine androgen synthesis in prostate cancer. Human prostate cancer cell lines, LNCaP and 22Rv1 cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ide, Hisamitsu, Lu, Yan, Noguchi, Takahiro, Muto, Satoru, Okada, Hiroshi, Kawato, Suguru, Horie, Shigeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891173/ https://www.ncbi.nlm.nih.gov/pubmed/29369461 http://dx.doi.org/10.1111/cas.13517

Ejemplares similares

Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males’ Symptoms Scores: A Pilot Study
por: Inoue, Yasuyuki, et al.
Publicado: (2018)

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens
por: Kitamura, Kosuke, et al.
Publicado: (2014)

Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer
por: Hirano, Hisashi, et al.
Publicado: (2020)

The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate
por: Saito, Keisuke, et al.
Publicado: (2015)

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
por: Ide, Hisamitsu, et al.
Publicado: (2014)

Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2013)

Chemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin
por: Horie, Shigeo
Publicado: (2012)

Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up
por: Horiuchi, Akira, et al.
Publicado: (2016)

Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy
por: Kitamura, Kosuke, et al.
Publicado: (2019)

A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience
por: Muto, Satoru, et al.
Publicado: (2017)

Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after Adrenalectomy
por: Inoue, Masahiro, et al.
Publicado: (2012)

Interferon-α Treatment for Growing Teratoma Syndrome of the Testis
por: Inoue, Masahiro, et al.
Publicado: (2013)

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
por: Ohtaka, Ayako, et al.
Publicado: (2019)

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
por: Kimura, Tomoki, et al.
Publicado: (2023)

A Japanese Box Lunch Bento Comprising Functional Foods Reduce Oxidative Stress in Men: A Pilot Study
por: Ide, Hisamitsu, et al.
Publicado: (2022)

Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review
por: Isotani, Shuji, et al.
Publicado: (2015)

Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan
por: Muto, Satoru, et al.
Publicado: (2021)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
por: Nagata, Masayoshi, et al.
Publicado: (2016)

Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model
por: Kim, Su Kang, et al.
Publicado: (2015)

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
por: Muto, Satoru, et al.
Publicado: (2017)

Cordyceps militaris Fruit Body Extract Decreases Testosterone Catabolism and Testosterone-Stimulated Prostate Hypertrophy
por: Kusama, Kazuya, et al.
Publicado: (2020)

The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer
por: Yin, Yarong Diana, et al.
Publicado: (2014)

Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease
por: Horie, Shigeo, et al.
Publicado: (2021)

Healthy Patients With AKR1D1 Mutation Not Requiring Primary Bile Acid Therapy: A Case Series
por: Kimura, Akihiko, et al.
Publicado: (2023)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
por: Lopez, David S., et al.
Publicado: (2017)

Combination of Lycopene and Curcumin Synergistically Alleviates Testosterone-Propionate-Induced Benign Prostatic Hyperplasia in Sprague Dawley Rats via Modulating Inflammation and Proliferation
por: Wang, Shanshan, et al.
Publicado: (2023)

AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol
por: Detlefsen, Andrea J., et al.
Publicado: (2023)

AKR1B10 expression in benign prostatic hyperplasia and its related mechanism
por: Xu, Wenjing, et al.
Publicado: (2021)

Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer
por: Fukuda, Kazuhiro, et al.
Publicado: (2022)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
por: Ieda, Takeshi, et al.
Publicado: (2016)

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
por: Nagaya, Naoya, et al.
Publicado: (2020)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses
Publicado: (1981)

Increase in salivary oxytocin and decrease in salivary cortisol after listening to relaxing slow-tempo and exciting fast-tempo music
por: Ooishi, Yuuki, et al.
Publicado: (2017)

Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
por: Schulze, Jenny J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5lbcdf606pjehteiaics34nccq